RxDoctor Payments Data

James Wisdo, DO

Family Medicine · Ocala, FLNPI 1508837998

Payments from drug & device makers

$975in general payments, 2019–2025

Across 62 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$454
  • Amgen$131
  • Lilly USA, LLC$108
  • AstraZeneca$93
  • Merck$64
  • Boehringer Ingelheim$60
  • plus $66 from 2 others

What the payments were for

  • Food & beverage$975100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$975 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$266,609
Medicare patients
235
Services billed
10,033

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate57$61,404
OzempicSemaglutide29$32,967
EliquisApixaban14$17,982
JardianceEmpagliflozin18$17,767
Repatha SureclickEvolocumab12$12,724
RybelsusSemaglutide12$12,306
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$8,008
Omeprazole199$4,395
Levothyroxine Sodium340$3,286
Rosuvastatin Calcium237$3,258
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,616
Gabapentin110$2,320
Atorvastatin Calcium192$2,261
Testosterone13$2,051
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,966

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$64$61,40457 claims
Novo NordiskOzempic, Rybelsus$454$45,27341 claims
Boehringer IngelheimJardiance$60$17,76718 claims
AstraZenecaBreztri Aerosphere$93$8,00812 claims
GSKShingrix$33$2,61612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →